May
22
2010
--

Insight Into The Future Of Cystic Fibrosis Offered By Older Patients

Originally posted in Cystic Fibrosis News From Medical News Today

An emerging population of middle-aged cystic fibrosis patients contains significantly more females and includes a large proportion of patients who lived for decades without a diagnosis or specialized care, according to research published by researchers at National Jewish Health…

Written by Cystic Fibrosis News From Medical News Today in: Cystic Fibrosis |

May
21
2010
0

Country Concert for Cystic Fibrosis

Country Concert for Cystic Fibrosis

Country Concert for Cystic Fibrosis

Written by Country Concert for Cystic Fibrosis in: Cystic Fibrosis |

May
20
2010
--

Mpex Pharmaceuticals Presents Positive Phase 2 Clinical Trial Results Of Aeroquin(TM) (MP-376) Treatment In Cystic Fibrosis Patients

Originally posted in Cystic Fibrosis News From Medical News Today

Mpex Pharmaceuticals, Inc. announced the presentation of data from its Phase 2b clinical trial with Aeroquin™ (a proprietary aerosol formulation of levofloxacin, MP-376) in cystic fibrosis (CF) at the American Thoracic Society (ATS) Annual Meeting in New Orleans…

Written by Cystic Fibrosis News From Medical News Today in: Cystic Fibrosis |

May
19
2010
--

Gregory Downey, MD, Honored For Scientific Accomplishments

Originally posted in Cystic Fibrosis News From Medical News Today

Gregory Downey, MD, received the 2010 Recognition Award for Scientific Accomplishments at the American Thoracic Society’s (ATS) International Conference on Monday, May 17. Dr. Downey, Executive Vice President of Academic Affairs and Professor of Medicine, Pediatrics and Immunology at National Jewish Health, has over 190 publications to his credit…

Written by Cystic Fibrosis News From Medical News Today in: Respiratory / Asthma |

May
18
2010
1

CF Foundation Announces Congressional Briefing

We are delighted to announce that Dr. Robert J. Beall, president and CEO of the CF Foundation and Dr. Francis S. Collins, director of the National Institutes of Health (NIH) will brief the United States Senate on the ongoing efforts to develop promising medical research for rare diseases this Thursday, May 20.

Call your senators today and urge them to attend this exciting event! The briefing will discuss how funding for medical research at NIH can be used to more quickly create new therapies for patients and save lives. The NIH is the primary federal agency for conducting and supporting medical research. Speakers will also discuss the lessons learned from the cystic fibrosis community’s successes in medical research that can map the way for other diseases.

Dr. Collins, a distinguished geneticist who led the international effort to map the human genome, is the co-discoverer of the cystic fibrosis gene.

Did you know that May is Cystic Fibrosis Awareness Month?

May is Cystic Fibrosis Awareness Month. You can help keep your members of Congress informed about the needs of people with cystic fibrosis by urging them to attend the Foundation’s congressional briefing on Thursday, May 20.

NIH Director Dr. Francis Collins talks about his dream for cystic
fibrosis and the future.
What: The Cystic Fibrosis Foundation and FasterCures invite you to a briefing that spotlights the nation’s investment in medical research at the NIH and examines how these dollars can be leveraged to create new therapies for patients and save lives.

Who:

  • Francis S. Collins, M.D., Ph.D., Director, National Institutes of Health
  • Senators Richard J. Durbin and Richard C. Shelby
  • Robert J. Beall, Ph.D., President and Chief Executive Officer, Cystic Fibrosis Foundation
  • Moderator: Margaret Anderson, Executive Director, FasterCures / The Center
    for Accelerating Medical Solutions

When: Thurs., May 20, 2010, 10 a.m. – 11 a.m.

Where: Dirksen Senate Office Building, G-11

Why: “The Cystic Fibrosis Foundation has shown the way, has lit up the path…and what’s been learned from CF can be extrapolated, generalized, to hundreds of other diseases,” Francis S. Collins, M.D., Ph.D., Director of the National Institutes of Health

The past few decades have brought exciting scientific breakthroughs necessary to understand, diagnose, and treat many diseases. However, the ability to translate exciting advancements into treatments that can help patients severely lags behind the pace of innovation.

On average, it takes 15 years to turn a scientific discovery into a viable therapy. For the millions of Americans who live with chronic and fatal diseases, this is simply too long to wait.

Fifty years ago, people with cystic fibrosis did not live long enough to attend grade school, but today, there are more than 30 drugs in a CF drug development pipeline and the median life expectancy for someone with the disease is 37 years.

NIH Director Dr. Francis S. Collins, Dr. Robert J. Beall of the Cystic Fibrosis Foundation, and Margaret Anderson of Faster Cures will address:

  • What lessons can be learned from the cystic fibrosis successes that can map the way for other diseases?
  • How can federal investment at the NIH and other agencies be leveraged to answer important scientific questions in a way that accelerates the discovery and development of medical solutions for deadly and debilitating diseases?
  • How can we bridge the “Valley of Death” between basic science discoveries and the creation of new therapies for patients?
Written by Country Concert for Cystic Fibrosis in: Cystic Fibrosis |

May
07
2010
1

Tell the Senate to Support the Clinical Trials Bill

The Cystic Fibrosis Foundation



Urge Your Senators to Pass the “Improving Access to Clinical Trials Act” Thanks to your hard work, the Improving Access to Clinical Trials Act now has more than 120 cosponsors in the House of Representatives! Your efforts have gotten us one step closer to helping new therapies for CF and other diseases move swiftly from the research stage into the hands of patients who need them.

However, we’re not done yet. Only 10 Senators have signed on to support this bipartisan bill, and we’re going to need a lot more to push the Improving Access to Clinical Trials Act across the finish line.

It’s up to you to ensure that both of your Senators are on board! Your efforts to get support for this bill in the Senate are more critical than ever.

Help ensure the bill passes in the Senate by:

  1. Emailing your Senators and asking them to cosponsor and support the bill’s passage in the Senate.
  2. Taking the additional step of calling your Senators to ask for their support.

Urge your Senators to add their names in support of the clinical trials bill and to pass it in 2010!

Thank you for your support!

MAKE AN IMPACT ON CF

SPEAK OUT
Get Started

GET INVOLVED
Sign up

INSPIRE ACTION
Recruit friends and family

Written by Country Concert for Cystic Fibrosis in: Cystic Fibrosis |

May
07
2010
--

Aradigm Receives FDA Clearance For Clinical Trial Of Inhaled Liposomal Ciprofloxacin In Pediatric Patients With Cystic Fibrosis

Originally posted in Cystic Fibrosis News From Medical News Today

Aradigm Corporation (OTCBB:ARDM) (the “Company”) announced it received clearance from the U.S. Food and Drug Administration (FDA) for its inhaled liposomal ciprofloxacin Investigational New Drug (IND) application…

Written by Cystic Fibrosis News From Medical News Today in: Cystic Fibrosis |

May
05
2010
--

Cystic Fibrosis Foundation Launches National Cycling Series To Benefit Critical Research And Care

Originally posted in Cystic Fibrosis News From Medical News Today

Thousands of cyclists will take to the streets this summer and fall as the Cystic Fibrosis Foundation launches a new cycling tour in 18 cities across the country to support research to find new therapies and a cure for cystic fibrosis. The tour series, known as ZENPEP® CF Cycle for Life begins in San Francisco on June 26. The event’s title sponsor is Eurand N.V…

Written by Cystic Fibrosis News From Medical News Today in: Cystic Fibrosis |

May
03
2010
1

Making "Great Strides" in Conquering Cystic Fibrosis

Making “Great Strides” in Conquering Cystic Fibrosis

Saturday, May 01 2010

WILKES-BARRE, LUZERNE COUNTY – Kirby Park was filled with walkers of all ages on Saturday.

They were there with one purpose in mind — to help conquer Cystic Fibrosis. It’s a life-shortening disease that strikes 30,000 children and adults — a disease that causes great difficulties with a person’s respiratory and digestive systems. “People with cystic fibrosis in order to live a healthy life face challenges every day… treatments to clear their lungs, enzymes before they eat,” said Linda Capozello.

She is Executive Director of the Cystic Fibrosis Foundation’s Northeastern Pennsylvania Chapter. She helped organize this Great Strides walk — a fund-raiser that’s drawn about twice as many walkers as last year. “Certainly when you have a childhood illness, people do come around and are very generous and kind and supportive,” said Capozellol. Many people decided to form teams for people they know who are stricken with cystic fibrosis. Crestwood 7th Grader Bethanie Jones formed Team Macho Brothers. She rounded up some friends to walk on behalf of her two cousins who both have cystic fibrosis. “I feel bad because they don’t really have a big life span and, like, I want them to survive as long as they can,” said the Luzerne County girl. “I want them to be normal and not have to worry about it when they get older.”

Getting older wasn’t much of an option for children with cystic fibrosis a half-century ago. Few lived long enough to enter grade school. But, today, many make it into adulthood. “The average life expectancy is now 37 years of age,” said Capozello. “But we’re making wonderful strides and we’re pushing that back literally by years.”

Giving people with cystic fibrosis — and their families — reason to keep trying to find a cure — one step at a time. The goal was to raise $35,000 at the Great Strides walk. All of the money raised goes toward research and treatment of cystic fibrosis.

Written by Country Concert for Cystic Fibrosis in: Cystic Fibrosis |

May
01
2010
--

The Journal of Cystic Fibrosis: Sunny perspectives

Originally posted in Journal of Cystic Fibrosis

The Journal of Cystic Fibrosis is the official Journal of the European Cystic Fibrosis Society (ECFS). The ECFS is a professional organisation and has members that form a wide range of disciplines including scientists, physicians, nurses and allied health professionals. The mission of ECFS is to facilitate the acquisition and sharing of knowledge and the improvement of patient care in all aspects of CF. An important instrument for this mission is the Journal. After nearly a decade, the Journal is now a well established source of valuable scientific and clinical information for individuals all over the world, interested in this hereditary disease. Cystic Fibrosis is a very complex disease which is mirrored by the high diversity of topics which are covered in the Journal (). Articles are published online and in the six yearly issues of the Journal or supplements.

Written by gerd doring in: Uncategorized |

Bookmark Us!

©Uncle & Drunken Crayfish Productions 2011 www.DrunkenCrayfish.com DrunkenCrayfish

Visit our NEW site at PocketBiker.com
PocketBiker.com Logo

 

TheBuckmaker.com Wordpress Themes | Hosting Provider, Mixed-Tape Free Music